The drug discovery process can be long and gruelling, but when backed by genetic evidence, drugs are twice as likely […]
Only 10% of new molecular entities that are in early clinical trials ever make it to approval. However, those with […]
‘Breaking bonds: a new enzyme to help drug discovery’ – Written by Charlotte Harrison, Science Writer. Amide bonds are strong […]
Register for our latest webinar series to learn how AI is being applied to all stages across the drug discovery […]
Drug discovery is a time-consuming and costly process, particularly given the high number of trials that ultimately “fail” or have […]
Join us for our latest webinar series, Genomics in Drug Discovery ONLINE, to discover how we can harness the latest […]
Join us for our latest 3-part webinar series, Biodata and AI in Drug Discovery, to uncover how experts organise data […]
Erik Ingelsson (Senior Vice President of Genomic Sciences at GlaxoSmithKline) joins us to discuss the importance of genetics in drug […]
Please note the transcript has been edited for brevity and clarity. FLG: Hello, everyone, and welcome to our interview with […]
Join us for Genomics in Drug Discovery ONLINE, a unique 3-part webinar series, where we explore the role of genetics […]
